BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18179135)

  • 21. Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer.
    Long KC; Zhou Q; Hensley ML; Alektiar KM; Gomez J; Gardner GJ; Chi DS; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2012 Apr; 125(1):99-102. PubMed ID: 22112609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ten years of experience with endometrial cancer treatment in a single Brazilian institution: Patient characteristics and outcomes.
    Anton C; Kleine RT; Mayerhoff E; Diz MDPE; Freitas D; Carvalho HA; Carvalho JPM; Silva ASE; Genta MLND; Silva ALFE; Salim RC; Aranha A; Lopez RVM; Carvalho FM; Baracat EC; Carvalho JP
    PLoS One; 2020; 15(3):e0229543. PubMed ID: 32134921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of solid growth in endometrioid endometrial adenocarcinoma.
    Akar S; Çelik ZE; Fındık S; İlhan TT; Ercan F; Çelik Ç
    Int J Clin Oncol; 2020 Jan; 25(1):195-202. PubMed ID: 31452018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular pathology of endometrial carcinoma: transcriptional signature in endometrioid tumors.
    Abal M; Planaguma J; Gil-Moreno A; Monge M; Gonzalez M; Baro T; Garcia A; Castellvi J; Ramon Y Cajal S; Xercavins J; Alameda F; Reventos J
    Histol Histopathol; 2006 Feb; 21(2):197-204. PubMed ID: 16329044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems.
    Alkushi A; Abdul-Rahman ZH; Lim P; Schulzer M; Coldman A; Kalloger SE; Miller D; Gilks CB
    Am J Surg Pathol; 2005 Mar; 29(3):295-304. PubMed ID: 15725797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification.
    Werner HM; Trovik J; Marcickiewicz J; Tingulstad S; Staff AC; Amant F; Salvesen HB;
    Gynecol Oncol; 2012 Apr; 125(1):103-8. PubMed ID: 22100838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A large-scale gene expression comparison of microdissected, small-sized endometrial cancers with or without hyperplasia matched to same-patient normal tissue.
    Sugiyama Y; Dan S; Yoshida Y; Akiyama F; Sugiyama K; Hirai Y; Matsuura M; Miyata S; Ushijima M; Hasumi K; Yamori T
    Clin Cancer Res; 2003 Nov; 9(15):5589-600. PubMed ID: 14654540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for lymph node metastases in women with endometrial cancer: A population-based, nation-wide register study-On behalf of the Swedish Gynecological Cancer Group.
    Stålberg K; Kjølhede P; Bjurberg M; Borgfeldt C; Dahm-Kähler P; Falconer H; Holmberg E; Staf C; Tholander B; Åvall-Lundqvist E; Rosenberg P; Högberg T
    Int J Cancer; 2017 Jun; 140(12):2693-2700. PubMed ID: 28340503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma.
    Hoang LN; McConechy MK; Köbel M; Anglesio M; Senz J; Maassen M; Kommoss S; Meng B; Postovit L; Kelemen LE; Staebler A; Brucker S; Krämer B; McAlpine JN; Gilks CB; Huntsman DG; Lee CH
    Int J Gynecol Cancer; 2015 Sep; 25(7):1187-93. PubMed ID: 26166557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer.
    Mazurek A; Kuc P; Terlikowski S; Laudanski T
    Neoplasma; 2006; 53(3):242-6. PubMed ID: 16652195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lynch syndrome--related endometrial carcinomas show a high frequency of nonendometrioid types and of high FIGO grade endometrioid types.
    Carcangiu ML; Radice P; Casalini P; Bertario L; Merola M; Sala P
    Int J Surg Pathol; 2010 Feb; 18(1):21-6. PubMed ID: 19443869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray.
    Dupont J; Wang X; Marshall DS; Leitao M; Hedvat CV; Hummer A; Thaler H; O'Reilly RJ; Soslow RA
    Gynecol Oncol; 2004 Aug; 94(2):449-55. PubMed ID: 15297187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
    Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
    Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
    [No Abstract]   [Full Text] [Related]  

  • 35. Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer.
    Risinger JI; Maxwell GL; Chandramouli GV; Jazaeri A; Aprelikova O; Patterson T; Berchuck A; Barrett JC
    Cancer Res; 2003 Jan; 63(1):6-11. PubMed ID: 12517768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers.
    Kharma B; Baba T; Mandai M; Matsumura N; Murphy SK; Kang HS; Yamanoi K; Hamanishi J; Yamaguchi K; Yoshioka Y; Konishi I
    Int J Cancer; 2013 Nov; 133(9):2234-44. PubMed ID: 23595697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance and diagnostic value of PTEN and p53 expression in endometrial carcinoma. A retrospective clinicopathological and immunohistochemical study.
    Daniilidou K; Frangou-Plemenou M; Grammatikakis J; Grigoriou O; Vitoratos N; Kondi-Pafiti A
    J BUON; 2013; 18(1):195-201. PubMed ID: 23613406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling.
    Wong YF; Cheung TH; Lo KW; Yim SF; Siu NS; Chan SC; Ho TW; Wong KW; Yu MY; Wang VW; Li C; Gardner GJ; Bonome T; Johnson WB; Smith DI; Chung TK; Birrer MJ
    Oncogene; 2007 Mar; 26(13):1971-82. PubMed ID: 17043662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of the 2009 FIGO staging for endometrial cancer: an illustration of the E3N cohort.
    Koskas M; Chabbert-Buffet N; Bendifallah S; Luton D; Clavel-Chapelon F; Rouzier R
    Int J Gynecol Cancer; 2012 Mar; 22(3):447-51. PubMed ID: 22367322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcript expression in endometrial cancers from Black and White patients.
    Maxwell GL; Allard J; Gadisetti CV; Litzi T; Casablanca Y; Chandran U; Darcy KM; Levine DA; Berchuck A; Hamilton CA; Conrads TP; Risinger JI
    Gynecol Oncol; 2013 Jul; 130(1):169-73. PubMed ID: 23603370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.